Envestnet Asset Management Inc. Sells 16,015 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Envestnet Asset Management Inc. trimmed its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 11.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 118,764 shares of the exchange traded fund’s stock after selling 16,015 shares during the period. Envestnet Asset Management Inc. owned about 0.19% of SPDR S&P Biotech ETF worth $9,632,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the business. Demars Financial Group LLC bought a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth $280,309,000. BlueCrest Capital Management Ltd purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at $138,051,000. Mirae Asset Securities USA Inc. lifted its position in shares of SPDR S&P Biotech ETF by 66.7% during the 4th quarter. Mirae Asset Securities USA Inc. now owns 1,500,000 shares of the exchange traded fund’s stock valued at $135,090,000 after buying an additional 600,000 shares during the last quarter. Bessemer Group Inc. lifted its position in shares of SPDR S&P Biotech ETF by 4.0% during the 1st quarter. Bessemer Group Inc. now owns 1,432,066 shares of the exchange traded fund’s stock valued at $116,141,000 after buying an additional 55,232 shares during the last quarter. Finally, RA Capital Management L.P. purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at $110,615,000.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA XBI opened at $86.27 on Monday. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $105.47. The business’s fifty day moving average price is $82.78 and its 200-day moving average price is $84.46. The stock has a market capitalization of $4.71 billion, a PE ratio of 11.47 and a beta of 0.97.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.